Skip to main content

How long can Kesimpta be out of the fridge?

Medically reviewed by Kristianne Hannemann, PharmD. Last updated on March 28, 2025.

Official answer

by Drugs.com

Kesimpta (ofatumumab) can be stored at room temperature (below 30°C / 86°F) for up to 7 days. This flexibility can be helpful when traveling or if refrigeration is temporarily unavailable.

Proper Storage Guidelines

Kesimpta should be kept in the refrigerator in the original carton to protect it from light. This applies to both the Sensoready pens and prefilled syringes. You can store Kesimpta in the refrigerator up to the expiration date written on the packaging.

Once you remove Kesimpta from the refrigerator, write the date in the space on the carton. This will help you remember how long the medication has been outside of the refrigerator. If Kesimpta has been stored at room temperature, it must be used within the next 7 days (even if you place it back in the refrigerator), or it must be thrown away after 7 days.

Do not freeze Kesimpta, because this could damage the medication.

By following these storage instructions, you ensure Kesimpta remains effective and safe for use. Talk to your healthcare provider if you have questions about storing Kesimpta.

References

Kesimpta [package insert]. Revised April 2024. Novartis Pharmaceuticals Corporation. Accessed 06/07/2024 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6a8a3f53-2062-48ff-9dbe-b939df133ca3

Read next

What are monoclonal antibodies?

Monoclonal antibodies (mAbs) are man-made proteins that mimic the natural antibodies produced by our immune systems. Monoclonal antibodies can be formulated into medicines to treat various types of illnesses, such as cancer, rheumatoid arthritis or psoriasis. Continue reading

Is Kesimpta better than Ocrevus?

In patients with relapsing forms of multiple sclerosis, Kesimpta (ofatumumab) is thought to be more effective than Ocrevus (ocrelizumab) in some ways, but no clinical trials have directly compared the two drugs

Ocrevus is the only one of the two drugs approved to treat primary progressive multiple sclerosis Continue reading

What are 8 key Kesimpta side effects to watch out for?

Kesimpta (ofatumumab) is an FDA-approved anti-CD20 monoclonal antibody used to treat relapsing forms of multiple sclerosis (MS) in adults. Like all medications, there are several side effects you should watch out for and know how to manage. Continue reading

Related medical questions

Drug information

Related support groups